Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Treasury Shares (2020 - 2023)

Historic Treasury Shares for Therapeutics (RAPT) over the last 4 years, with Q4 2023 value amounting to $13500.0.

  • Therapeutics' Treasury Shares fell 5000.0% to $13500.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $13500.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $13500.0 for FY2023, which is 5000.0% down from last year.
  • Therapeutics' Treasury Shares amounted to $13500.0 in Q4 2023, which was down 5000.0% from $13500.0 recorded in Q3 2023.
  • Over the past 5 years, Therapeutics' Treasury Shares peaked at $56500.0 during Q2 2020, and registered a low of $13500.0 during Q1 2023.
  • Its 4-year average for Treasury Shares is $32900.0, with a median of $27000.0 in 2022.
  • Per our database at Business Quant, Therapeutics' Treasury Shares plummeted by 2831.86% in 2021 and then plummeted by 5000.0% in 2023.
  • Therapeutics' Treasury Shares (Quarter) stood at $56500.0 in 2020, then decreased by 28.32% to $40500.0 in 2021, then crashed by 33.33% to $27000.0 in 2022, then tumbled by 50.0% to $13500.0 in 2023.
  • Its Treasury Shares was $13500.0 in Q4 2023, compared to $13500.0 in Q3 2023 and $13500.0 in Q2 2023.